Tenax Therapeutics TENX
NASDAQ TENX
$1.75 -0.03 (-1.68%)
As of: Aug 21, 2026 · 2:19 PM EDT

Tenax Therapeutics (TENX) EBITDA Margin (QoQ) (2011 - 2013)

Tenax Therapeutics (TENX) EBITDA Margin (QoQ) (2011 - 2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.93 Bn 131.08 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.11 Bn 78.11 Bn 3.93 Bn
3 Argenx Se 65.43 Bn 60.25 Bn 1.37 Bn
4 Moderna 56.09 Bn 50.96 Bn 52.00 Mn
5 BeOne Medicines 42.13 Bn 37.03 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.68 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.49 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 Tenax Therapeutics 79.37 Mn 79.37 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2013 -22,318.00
Jan 31, 2013 -58,160.00
Oct 31, 2012 49,453.00
Jul 31, 2012 132,365.00
Apr 30, 2012 -66,970.00
Jan 31, 2012 256,644.00
Oct 31, 2011 591,294.00
Jul 31, 2011 -1.59 Mn